Uniplan Investment Counsel, Inc. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Uniplan Investment Counsel, Inc. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q2 2019$982,000
-43.2%
97,375
-21.1%
0.06%
-43.6%
Q1 2019$1,730,000
-25.1%
123,339
-15.3%
0.11%
-30.8%
Q4 2018$2,311,000
-18.2%
145,677
-3.0%
0.16%
-3.0%
Q3 2018$2,824,000
-12.6%
150,171
-10.6%
0.16%
+3.8%
Q2 2018$3,231,000
-21.6%
167,932
-13.0%
0.16%
-18.1%
Q1 2018$4,123,000
+1.9%
193,064
-1.9%
0.19%
+17.0%
Q4 2017$4,047,000
+14.5%
196,882
+2.6%
0.16%
+10.7%
Q3 2017$3,535,000
-44.1%
191,822
-24.4%
0.15%
-46.4%
Q2 2017$6,329,000
+24.2%
253,651
-0.2%
0.28%
+20.3%
Q1 2017$5,095,000
-17.0%
254,159
+2.2%
0.23%
-17.2%
Q4 2016$6,138,000
-31.8%
248,730
-45.3%
0.28%
-31.1%
Q3 2016$9,006,000
+47.0%
454,421
+1.9%
0.40%
+46.2%
Q2 2016$6,127,000
+5.9%
445,913
+6.0%
0.28%
-2.8%
Q1 2016$5,785,000
+36.1%
420,724
+0.3%
0.28%
+38.3%
Q4 2015$4,251,000
+2.8%
419,281
+1.9%
0.21%
+3.5%
Q3 2015$4,135,000
-23.6%
411,446
+12.8%
0.20%
-19.1%
Q2 2015$5,410,000364,8310.25%
Other shareholders
PSYCHEMEDICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
Ancora Advisors LLC 78,373$311,1410.01%
WEDBUSH SECURITIES INC 42,414$1680.01%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Your Advocates Ltd., LLP 1,400$5,5580.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders